Latest news with #patientvisits
Arabian Business
6 days ago
- Business
- Arabian Business
Burjeel bounces back with strong Q2 numbers after March lows
With a rise in its number of inpatient and outpatient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network, Burjeel Holdings announced an impressive 128.9 per cent jump in net profit to AED 148 million (US$40.3 million) in the second quarter of 2025. Net profit for the first six months rose 10.6 per cent to AED 187 million (US$50.9 million). The rise in net profit for Q2 was also due to a decline in footfall for the month of March, which was attributed by the company to the Holy Month of Ramadan. Those numbers were overwhelmingly reversed in the second quarter of the year, as inpatient footfall rose 17.7 per cent, and outpatient footfall grew 12 per cent. Revenue grew 18.7 per cent to AED 1,403 million (US$382 million) in Q2'25, while revenue for the first six months rose 12.2 per cent to AED 2,677 million (US$728.9 million). Total patient visits reached 3.4 million. The Group performed 22,930 surgeries, up 18.7 per cent. Bed occupancy improved to 69 per cent, up from 65 per cent a year ago. Inpatient volumes rose 14.6 per cent over the first half. The outpatient footfall was driven by primary care and physiotherapy centers, along with strong demand in oncology, pediatrics, ophthalmology, and family medicine. Utilisation improved to 68 per cent, up from 65 per cent in Q1'25. Oncology remained a core growth driver, with revenue rising 36.7 per cent in Q2'25 and 38.1 per cent in H1'25. This was made possible by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded good gains in H1'25, including urology (+18 per cent), emergency medicine (+17 per cent) and cardiology (+16 per cent). John Sunil, Chief Executive Officer of Burjeel Holdings, commented: 'The second quarter delivered exceptionally strong results, with 19 per cent revenue growth driven by a 12 per cent increase in patient footfall and improved yield. EBITDA rose by 59 per cent, accompanied by a margin uplift to 22 per cent. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth. 'These results reflect tangible progress in key operational areas such as physician manpower optimisation, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum. 'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities.' EBITDA rose 59.4 per cent to AED 306 million (US$83.3 million) in Q2'25, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED 72 million (US$19.6 million) in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 points to 21.8 per cent. In H1'25, EBITDA increased 14.2 per cent to AED 487 million (US$132.6 million). 'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value,' Sunil added. 'Net profit growth of 129 per cent in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.'
National Post
08-05-2025
- Business
- National Post
WELL Health Reports Record Patient Visits and Total Care Interactions in Q1 2025 and Provides Date for Earnings Event
Article content WELL delivered more than 1.6 million patient visits in Q1 2025 representing system-wide YoY growth of 24% driven by organic growth of 14%. WELL Canada's patient services business led its overall growth with over 933,000 patient visits representing YoY growth of 30% growth and organic growth of 12%. WELL to announce First Quarter Financial Results on May 14, 2025. Article content Article content VANCOUVER, British Columbia & TORONTO — WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (' WELL ' or the ' Company '), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce the Company will release its Fiscal First Quarter 2025 financial results for the period March 31, 2025, on Wednesday, May 14, 2025 and strong preliminary operational results for its Patient Services businesses for Q1 2025. These results include record patient visits and Total Care Interactions. Article content Hamed Shahbazi, Founder and CEO of WELL, commented, 'We had excellent growth in our patient visits this past quarter underpinned by our Canadian clinics ecosystem. Canadian Clinics continued their rapid growth with 30% YoY growth which included 12% organic growth driven by our clinic absorption program. Our core fundamentals continue to be strong as we execute on both organic and inorganic growth consistently. We are now approaching 1 million patient visits per quarter just in Canada which we believe to be an important milestone. Our technology enabled care delivery model continues to benefit care providers who are seeing improved efficiency, reduced administrative burden and improved patient outcomes. We are very proud of and grateful to the healthcare providers and technologists working together to drive the best patient outcomes possible.' Article content WELL Canada Clinics Annual Growth Breakdown Article content Circle Medical Deferred Revenue Impact in 2025 Article content In connection with the previously disclosed requirement for the Company's subsidiary Circle Medical to defer the recognition of revenue under IFRS, the net impact to WELL's Q1-2025 revenue and Adjusted EBITDA is expected to be ($6.5M). As at March 31, 2025, the Company expects to record approximately $58.4 million in deferred revenue on its consolidated balance sheet, related to patient services that have been rendered and for which payment has already been billed and collected. Article content Q1 2025 Earnings Announcement Article content The Company will release its Q1 2025 earnings for the period March 31, 2025, on Wednesday, May 14, 2025, and hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00 pm ET (10:00 am PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer and Eva Fong, Chief Financial Officer. Please dial in 10 minutes prior to the start of the call. Article content Conference Call Participant Details Article content Date: Wednesday, May 14, 2025 Article content Time: 1:00 PM ET / 10:00 AM PT Article content International Toll: 1-289-514-5100 Article content North American Toll Free: 1-800-717-1738 Article content Footnotes: Article content Technology Interactions means the total number of bookings facilitated by certain technology platforms including OceanMD, Insig, and Adracare. Billed Provider Hours means the hours that providers bill under RADAR Healthcare Providers which is owned and operated by WELL's CRH Medical Subsidiary. Article content Per: 'Hamed Shahbazi' Article content Hamed Shahbazi Article content Chief Executive Officer, Chairman and Director Article content WELL's mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL's comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL's solutions enable more than 41,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL's solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol 'WELL' and on the OTC Exchange under the symbol 'WHTCF'. To learn more about the Company, please visit: Article content Forward Looking Statements Article content This news release contains 'Forward-Looking Information' within the meaning of applicable Canadian securities laws, including, without limitation the expectation that patient visits and Total Interactions will continue to lead the way in driving strong organic growth for the Company enterprise wide, and the anticipated impact of deferred revenue on the Company's Q1-2025 revenue and Adjusted EBITDA. Forward-Looking Information is based on a number of estimates and assumptions are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond WELL's control, which could cause actual results and events to differ materially from those disclosed in this news release. Forward-Looking Information generally can be identified by the use of forward-looking words such as 'may', 'should', 'will', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe', 'goal' or 'continue', or the negative thereof or similar variations. Forward-Looking Information involves known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information is not a guarantee of future results or performance. WELL's comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL's control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including, but not limited to: continued demand for in-person and telehealth medical services; new technologies functioning as expected; customers adopting and using new technologies and services as expected; the need to develop increasingly innovative products and services; competition in the industry; the retention of patients; the stability of general economic and market conditions; WELL's ability to comply with applicable laws and regulations; WELL's continued compliance with third party intellectual property rights; direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; litigation risk; that future results may vary from historical results; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at including its most recent Annual Information Form and its most recent Management, Discussion and Analysis. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise. Article content Article content Article content Article content Article content Contacts Article content Article content Article content
The Sun
07-05-2025
- Health
- The Sun
Scots hospital locks down all wards after outbreak of highly contagious virus
A HOSPITAL has reportedly been locked down as highly contagious virus causes chaos. Belford Hospital in Fort William has been hit by several cases of Norovirus. It's understood that health chiefs have restricted patient visits and are only allowing essential loved ones onto the wards. An NHS Highland spokesperson said: "We have had to close both wards in Belford Hospital to new admissions due to Norovirus." More to follow... For the latest news on this story keep checking back at The Scottish Sun. is your go to destination for the best celebrity news, football news, real-life stories, jaw-dropping pictures and must-see video. Like us on Facebook at and follow us from our main Twitter account at @TheScottishSun. 1
